CRL · 8-K · 20260805PR000115

Capital Expenditures

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · 2026-08-05 · Importance 36 · Surprise 14

Six-month capital expenditures were $87.0 million, down from $94.6 million in the prior-year period. Second-quarter capital expenditures were $31.1 million, compared with $35.3 million in the second quarter of 2025. DSA invested $57.9 million in capital expenditures during the first six months, while RMS invested $16.6 million and Manufacturing Solutions invested $11.9 million. Six-month operating cash flow was $220.8 million, providing coverage of approximately 2.5 times capital expenditures.

Key facts

• Total capital expenditures for the six months ended June 27, 2026: $87,013 thousand. source
• DSA capital expenditures for the three months ended June 27, 2026: $20,433 thousand; for six months: $57,942 thousand. source
• Capital expenditures for the three months ended June 27, 2026: $31,105 thousand (total) and $31,105 shown as capital expenditures in reconciliation schedule. source
• RMS capital expenditures for the three months ended June 27, 2026: $4,989 thousand; for six months: $16,557 thousand. source
• Manufacturing capital expenditures for the three months ended June 27, 2026: $5,634 thousand; for six months: $11,908 thousand. source